Germany · Delayed Price · Currency is EUR Enzymatica AB Statistics
Total Valuation
Enzymatica AB has a market cap or net worth of EUR 40.91 million. The enterprise value is 38.01 million.
| Market Cap | 40.91M |
| Enterprise Value | 38.01M |
Important Dates
The next estimated earnings date is Wednesday, February 18, 2026.
| Earnings Date | Feb 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 242.74M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +40.22% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 7.00% |
| Owned by Institutions (%) | 14.41% |
| Float | 106.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.58 |
| PB Ratio | 3.33 |
| P/TBV Ratio | 6.37 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -7.76 |
| EV / Sales | 7.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.74 |
Financial Position
The company has a current ratio of 5.25, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.25 |
| Quick Ratio | 3.91 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.02 |
| Interest Coverage | -134.44 |
Financial Efficiency
Return on equity (ROE) is -33.30% and return on invested capital (ROIC) is -20.84%.
| Return on Equity (ROE) | -33.30% |
| Return on Assets (ROA) | -18.98% |
| Return on Invested Capital (ROIC) | -20.84% |
| Return on Capital Employed (ROCE) | -40.37% |
| Revenue Per Employee | 227,118 |
| Profits Per Employee | -233,204 |
| Employee Count | 21 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.26 |
Taxes
| Income Tax | -9,407 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +6.72% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +6.72% |
| 50-Day Moving Average | 0.16 |
| 200-Day Moving Average | 0.22 |
| Relative Strength Index (RSI) | 45.67 |
| Average Volume (20 Days) | n/a |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Enzymatica AB had revenue of EUR 4.77 million and -4.90 million in losses. Loss per share was -0.02.
| Revenue | 4.77M |
| Gross Profit | 3.04M |
| Operating Income | -4.96M |
| Pretax Income | -4.91M |
| Net Income | -4.90M |
| EBITDA | -4.72M |
| EBIT | -4.96M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 2.99 million in cash and 118,038 in debt, giving a net cash position of 2.87 million.
| Cash & Cash Equivalents | 2.99M |
| Total Debt | 118,038 |
| Net Cash | 2.87M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 12.27M |
| Book Value Per Share | 0.05 |
| Working Capital | 5.14M |
Cash Flow
In the last 12 months, operating cash flow was -5.61 million and capital expenditures -36,361, giving a free cash flow of -5.64 million.
| Operating Cash Flow | -5.61M |
| Capital Expenditures | -36,361 |
| Free Cash Flow | -5.64M |
| FCF Per Share | n/a |
Margins
Gross margin is 63.76%, with operating and profit margins of -104.02% and -102.68%.
| Gross Margin | 63.76% |
| Operating Margin | -104.02% |
| Pretax Margin | -102.88% |
| Profit Margin | -102.68% |
| EBITDA Margin | -99.05% |
| EBIT Margin | -104.02% |
| FCF Margin | n/a |
Dividends & Yields
Enzymatica AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -40.22% |
| Shareholder Yield | -40.22% |
| Earnings Yield | -11.97% |
| FCF Yield | -13.80% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |